Loading clinical trials...

Study on the Effectiveness of Berlin Dissexuality Therapy as Part of the Model Project in Accordance With §65d SBG V | Clinical Trials | Clareo Health

NOT_YET_RECRUITINGNA

Study on the Effectiveness of Berlin Dissexuality Therapy as Part of the Model Project in Accordance With §65d SBG V

BEDIT-RCT: Randomized Controlled Study on the Effectiveness of Berlin Dissexuality Therapy as Part of the Model Project in Accordance With §65d German Social Security Code V

NCT06607042•Charite University, Berlin, Germany

View on ClinicalTrials.gov

Summary

The main goal of this clinical trial is to learn if psychotherapy works to reduce consumption of child abuse imagages.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Age at first presentation minimum 18 years
•Voluntary consent to participation on the part of the participant
•At the time of inclusion, no contact with the justice system (ongoing investigation, ongoing criminal proceedings, ongoing prison sentence) due to sexually abusive behavior towards children
•Sexually conspicuous behavior and/or fantasies or impulses that indicate the presence of a pedophilic and/or hebephilic preference disorder.
•An offer of treatment is made when a suspected diagnosis is confirmed or the diagnosis is confirmed
•Feared or recent use of abusive images
•Sufficient knowledge of German
•Voluntary participation in the study and checking the checkbox in the informed consent form before starting participation

Exclusion Criteria

•Age under 18 years
•Lack of consent on the part of the patient
•Exclusion of the presence of a pedophilic and/or hebephilic preference disorder
•Current legal status in the sense of an ongoing investigation or criminal proceedings due to sexually assaultive behavior towards children
•Severe comorbidities: unstable psychotic disorder, organic brain damage, reduced intellectual capacity (IQ below 70), untreated drug or alcohol addiction or persistent harmful use
•Current risk of child sexual abuse and or child sexual abuse that occurred less than 15 years before the start of the study
•An antiandrogenic medication or an opiate antagonist, during therapy start taking a serotonin reuptake inhibitor.

Key Dates

Start Date

September 16, 2024

Primary Completion Date

December 31, 2025

Completion Date

December 31, 2025

Last Updated

September 23, 2024

Enrollment

ESTIMATED participants

Conditions

PaedophiliaHebephilia

Interventions

Psychotherapy

BEHAVIORAL

Contacts

Klaus Michael Beier, Prof. Dr. med. Dr. phil.

CONTACT

+49 30450529301 klaus.beier@charite.de

Tillmann Krüger, Prof. Dr. med.

CONTACT

+49 5115322470 krueger.tillmann@mh-hannover.de

Talking for Change: Secondary Prevention of Child Sexual Abuse Perpetration

NCT07001735

PedophiliaHebephilia+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 23, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions